← FDA DRUG APPROVALS
FDA ANDA · ANDA091344
HAIR REGROWTH TREATMENT
minoxidil
Sponsor: PERRIGO PHARMA INTL
APPLICATION
ANDA091344
TYPE
ANDA
ORIGINAL APPROVAL
2011-04-28
LATEST ACTION
2020-06-10
ROUTE
TOPICAL
DOSAGE FORM
AEROSOL, FOAM
MARKETING STATUS
Over-the-counter
Products
MINOXIDILOver-the-counter
MINOXIDIL 5% · AEROSOL, FOAM · TOPICAL
Approval history
2020-06-10Labeling · Supplement 20 · standardAP
2017-03-03Labeling · Supplement 16 · standardAP
2016-11-13Labeling · Supplement 14 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.